Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
An Erratum on
Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
by He, L., Chen, M., Liang, Q., Wang, Y., and Tan, W. (2022). Front. Pharmacol. 12:775084. doi:10.3389/fphar.2021.775084
Due to a production error, “Zhangfeng Zhong” was not included as an author in the published article.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: coptidis rhizoma, medicinal plant, gastrointestinal cancer, omics, clinical research
Citation: Frontiers Production Office (2022) Erratum: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers. Front. Pharmacol. 13:931882. doi: 10.3389/fphar.2022.931882
Received: 29 April 2022; Accepted: 29 April 2022;
Published: 26 May 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org